KIN Human

KIN Human Recombinant
Shipped with Ice Packs
In Stock

Description

KIN Human Recombinant produced in E. coli is a single polypeptide chain containing 416 amino acids (1-393) and having a molecular mass of 47.8 kDa.
KIN is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
The DNA/RNA-binding protein KIN17 (KIN17) is found within the nucleus and forms intranuclear foci during cell proliferation. It redistributes within the nucleoplasm during the cell cycle. KIN17 is expressed ubiquitously, with the highest levels of expression occurring in muscle, heart, and testis tissues. Overexpression of KIN17 has been observed in SV40-altered fibroblasts. KIN17 interacts with Large T antigen and reduces T-antigen-dependent DNA replication.
Description
Recombinant human KIN, expressed in E. coli, is a single polypeptide chain with a molecular weight of 47.8 kDa. The protein consists of 416 amino acids, including a 23 amino acid His-tag fused to the N-terminus (amino acids 1-393). Purification is achieved through proprietary chromatographic techniques.
Physical Appearance
A sterile and colorless solution.
Formulation
The KIN solution has a concentration of 0.5 mg/ml and is supplied in a buffer containing 20mM Tris-HCl (pH 8.0), 0.2M NaCl, and 20% glycerol.
Stability
For short-term storage (up to 4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein, such as 0.1% HSA or BSA, is advised for long-term storage. Repeated freeze-thaw cycles should be avoided.
Purity
The purity is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
BTCD, KIN17, KIN, Binding to curved DNA, antigenic determinant of recA protein homolog, DNA/RNA-binding protein KIN17.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMGKSDFL TPKAIANRIK SKGLQKLRWY CQMCQKQCRD
ENGFKCHCMS ESHQRQLLLA SENPQQFMDY FSEEFRNDFL ELLRRRFGTK RVHNNIVYNE YISHREHIHM NATQWETLTD FTKWLGREGL CKVDETPKGW YIQYIDRDPE TIRRQLELEK
KKKQDLDDEE KTAKFIEEQV RRGLEGKEQE VPTFTELSRE NDEEKVTFNL SKGACSSSGA
TSSKSSTLGP SALKTIGSSA SVKRKESSQS STQSKEKKKK KSALDEIMEI EEEKKRTART
DYWLQPEIIV KIITKKLGEK YHKKKAIVKE VIDKYTAVVK MIDSGDKLKL DQTHLETVIP
APGKRILVLN GGYRGNEGTL ESINEKTFSA TIVIETGPLK GRRVEGIQYE DISKLA.

Q&A

What is the neurobiological basis of human olfactory kin recognition?

Human olfactory kin recognition represents an evolutionary mechanism that allows individuals to distinguish relatives from non-relatives based solely on body odor cues. Unlike visual or auditory kin recognition, olfactory recognition typically occurs with minimal conscious awareness, making it an excellent model for studying biological recognition mechanisms. Neuroimaging research has identified specific brain regions involved in this process, including the frontal-temporal junction, insula, and dorsomedial prefrontal cortex . These regions differ from the classic olfactory processing pathway (piriform and orbitofrontal cortex), suggesting specialized neural circuits for processing socially relevant odors . This system is thought to promote genetic fitness through facilitating nepotism and helping avoid inbreeding .

How are experimental protocols designed for human kin recognition studies?

Experimental protocols for olfactory kin recognition typically involve carefully controlled collection and presentation of body odor samples:

Experimental PhaseMethodological Considerations
Odor collectionParticipants wear clean t-shirts for 7-8 days while following strict protocols to avoid contamination from external scents
Screening procedureCollected samples are screened for contamination by researchers
Stimulus presentationIntermittent stimulus presentation (3s with 5s intervals) to limit adaptation
Neuroimaging setupStimuli presented 10s prior to radiotracer injection in PET studies
Control conditionsPerceptually similar non-body odors used as controls

Researchers address methodological challenges through standardized procedures that include screening participants for olfactory function and employing multiple experimental conditions to isolate kin recognition from general olfactory processing .

Why is neuroimaging particularly valuable for studying kin recognition?

Neuroimaging offers unique advantages for investigating kin recognition mechanisms because:

  • It allows measurement of neural responses without requiring conscious identification, circumventing the confounding effects of explicit recognition

  • PET imaging with H2O15 enables direct presentation of unaltered body odors during scanning

  • It can detect subtle processing differences even when behavioral responses are similar

  • Multiple conditions (sister's body odor, friend's body odor, odor control, odorless baseline) can be compared within the same experimental session

  • It reveals that body odors activate networks distinct from common olfactory pathways, indicating specialized processing

Research demonstrates that the neuronal response to kin odors is independent of conscious identification, confirming that humans possess an odor-based kin detection system similar to other mammals .

What methodological challenges exist in isolating kin recognition from general olfactory processing?

Researchers face several key challenges:

  • Controlling conscious recognition: Unlike other sensory modalities, olfaction allows for studying kin recognition with minimal conscious identification, but requires careful experimental design

  • Stimulus standardization: Body odors vary substantially between individuals and within individuals over time

  • Participant compliance: Ensuring donors follow strict protocols for odor collection (avoiding scented products, following controlled diets, etc.)

  • Perceptual similarity: Creating appropriate control stimuli that match body odors in perceptual qualities without activating kin recognition processes

  • Neuroimaging limitations: Traditional protocols must be adapted for olfactory stimulation timing and presentation

Advanced research addresses these challenges through specialized collection protocols, intermittent stimulus presentation, and multivariate analysis techniques to detect subtle response patterns .

How do researchers distinguish between conscious and unconscious kin recognition?

Distinguishing between conscious and unconscious processes requires specific methodological approaches:

  • Behavioral measures: Assessing recognition accuracy while controlling for confidence levels

  • Stimulus presentation timing: Using brief exposures that limit conscious analytical processing

  • Attention direction: Instructing participants to focus on breathing normally rather than identifying odors

  • Neural response patterns: Comparing activation in regions associated with conscious recognition versus implicit processing

  • Comparison with non-kin controls: Using longtime friends as controls to match familiarity while differing in genetic relatedness

Research shows that accurate kin identification occurs despite low conscious recognition of the individual source, demonstrating the primarily unconscious nature of this evolutionary mechanism .

What computational approaches address the limited structural coverage of the human kinome?

Despite the importance of the human kinome (comprising >500 protein kinase genes), experimental structures exist for only about 20% of human kinases . To bridge this gap, researchers employ:

  • Template-based modeling: Constructing structural models for all kinase domains based on related kinases with known structures

  • Structure/evolution-based approaches: Precisely detecting target sites despite potential structural inaccuracies

  • Hierarchical virtual screening: Combining ligand-based and structure-based filters to compensate for modeling limitations

  • Machine learning integration: Training classifiers on available selectivity data to improve predictive accuracy

The X-ReactKIN approach exemplifies this methodology, achieving approximately 70% sensitivity in identifying alternate molecular targets in the human kinome with a relatively low false positive rate (<0.5) .

Why are kinases challenging targets for selective drug development?

Developing selective kinase inhibitors presents several significant challenges:

ChallengeScientific BasisResearch Implication
Structural conservationATP-binding site and catalytic mechanism highly conserved across the kinome Similar compounds may inhibit multiple kinases
Sequence similarity thresholdsKinases with 50-60% sequence identity often have similar pharmacological profiles Difficult to predict cross-reactivity based on sequence alone
Binding site flexibilityActive sites can adopt multiple conformations Static structural models may miss important interactions
Limited experimental structuresOnly ~20% of human kinome has crystal structures Reliance on predicted models introduces uncertainty

These challenges necessitate sophisticated computational approaches that integrate sequence, structure, and ligand binding similarities to predict potential cross-reactivity .

How does the X-ReactKIN approach predict kinase inhibitor cross-reactivity?

X-ReactKIN represents an advanced machine learning approach that extends modeling from individual kinases to system-level cross-reactivity profiling:

  • Structural modeling: Constructs models for all kinase domains in humans using template-based approaches

  • Target site detection: Applies structure/evolution-based techniques to identify binding sites

  • Virtual screening: Employs hierarchical filtering against commercial compound libraries

  • Classifier training: Uses a Naive Bayes classifier trained on available inhibitor selectivity data

  • CR-score calculation: Generates a probabilistic cross-reactivity score combining multiple similarity metrics

This approach enables researchers to construct a comprehensive cross-reactivity matrix for the entire human kinome, facilitating the development of more selective inhibitors by identifying potential off-target interactions .

What classification schemas help understand the kinome functional space?

Multiple classification approaches have been developed to organize the kinome and predict functional similarities:

  • Sequence-based classification: Organizes kinases into 30 distinct families based on global sequence similarity

  • Structure-based approaches: Uses 3D structural comparisons of ATP-binding sites

  • SAR-based dendograms: Clusters kinases based on small molecule inhibition patterns

  • Feature-similarity matrices: Combines structural features with pharmacological distance measures

  • QSAR analysis: Evaluates residue contributions to inhibition profiles

Research demonstrates that different classification methods yield divergent results, particularly for distantly homologous targets. Sequence-based approaches require very high identity thresholds (>50-60%) to predict similar pharmacological profiles, whereas structural approaches can detect functional similarities despite lower sequence conservation .

How can computational predictions guide experimental kinase inhibitor development?

Computational approaches can strategically guide experimental efforts in several ways:

  • Prioritizing counter-screen experiments: Identifying the most likely off-target kinases for experimental testing

  • Rationalizing observed cross-reactivity: Explaining molecular mechanisms of inhibitor promiscuity

  • Guiding structure-activity relationship studies: Suggesting structural modifications to improve selectivity

  • Identifying unexplored chemical space: Finding novel scaffolds with potentially improved selectivity profiles

  • Optimizing screening panels: Designing kinase panels that efficiently sample the diversity of the kinome

The X-ReactKIN system, freely available to academic researchers, provides a practical tool for identifying potential cross-reactivity issues early in the drug development process, potentially reducing late-stage failures due to off-target effects .

What does "making kin with research ethics" mean in academic research?

"Making kin with research ethics" represents a conceptual framework for understanding research ethics as a relational practice rather than merely a procedural requirement. Drawing from Donna Haraway's work, this approach views ethics as emerging from networks of relationships and responsibilities that form during the research process . Key principles include:

  • Recognition that research environments are co-constituted by all participants

  • Understanding that relationships "collapse or converge" in research ethics contexts

  • Acknowledgment that research relationships create responsibilities and accountabilities

  • Viewing ethics as an ongoing process of negotiation rather than a fixed set of guidelines

This approach extends ethical considerations beyond compliance with institutional review boards to encompass the complex web of relationships formed throughout the research process .

How do power dynamics affect research relationships?

Academic research inherently involves complex power dynamics that shape ethical responsibilities:

Relationship TypePower DynamicsEthical Considerations
Supervisor-StudentHierarchical authority, evaluation powerIntellectual ownership, appropriate mentorship
Researcher-ParticipantControl over research processInformed consent, representation
Researcher-AdministratorRegulatory authority, institutional prioritiesNavigating procedural requirements
Colleague-ColleagueResource access differences, institutional statusCredit attribution, collaborative decision-making

These power differentials require ongoing reflection and management throughout the research process. Research suggests that acknowledging power imbalances explicitly can help create more ethical research environments, particularly when paired with mechanisms for distributing decision-making authority where appropriate .

How do Research Ethics Boards function as nodal points in research relationship networks?

Research Ethics Boards (REBs, also known as Institutional Review Boards or IRBs) serve as crucial nodal points in the network of research relationships:

  • They mediate between institutional requirements and researcher autonomy

  • They establish minimum standards for ethical treatment of participants

  • They create formal documentation of ethical commitments

  • They represent institutional interests in risk management and compliance

  • They connect individual research projects to broader ethical frameworks

What methodological approaches help navigate complex relationships with research participants?

Several methodological approaches can help researchers navigate ethical relationships with participants:

  • Reflexive practice: Regular reflection on power dynamics within research relationships

  • Transparent communication: Clearly articulating expectations and responsibilities

  • Collaborative design: Involving participants in shaping research questions and methodologies

  • Ongoing consent processes: Treating consent as a continuing conversation rather than a one-time event

  • Accountability mechanisms: Creating structures for participants to provide feedback throughout the research process

These approaches recognize that ethical relationships develop over time and require constant attention to shifting power dynamics and evolving responsibilities .

How can researchers balance hierarchical academic structures with ethical research relationships?

Balancing hierarchical structures with ethical relationships requires specific strategies:

  • Acknowledging relative privilege and vulnerability within academic hierarchies

  • Creating transparent decision-making processes that document rationales

  • Establishing clear protocols for resolving conflicts that arise from power differentials

  • Recognizing diverse forms of expertise and contribution beyond formal academic positions

  • Implementing collaborative writing and publication processes that fairly represent all contributions

Research indicates that while academic hierarchies cannot be eliminated, their potential negative impacts can be mitigated through intentional practices that distribute agency and recognize interdependence . As Haraway argues, making kin "troubles important matters, like to whom one is actually responsible," challenging researchers to expand their understanding of ethical obligations within academic contexts .

Product Science Overview

Structure and Source

The recombinant human KIN protein is typically produced in Escherichia coli (E. coli) and is often tagged with a His-tag at the N-terminus to facilitate purification. The protein corresponds to the amino acids 1-393 of the human KIN sequence . The theoretical molecular weight of the recombinant KIN protein is approximately 47.8 kDa, although the observed molecular weight may vary due to post-translational modifications and other experimental factors .

Expression and Function

KIN17 is ubiquitously expressed in various tissues, with the highest levels found in muscle, heart, and testis . This protein is involved in binding to curved DNA and has been shown to interact with the Large T antigen in SV40-transformed fibroblasts, reducing T-antigen-dependent DNA replication . The overexpression of KIN17 in these fibroblasts suggests its potential role in regulating DNA replication and maintaining genomic stability.

Applications and Research

Recombinant human KIN protein is widely used in research to study its role in DNA replication, repair, and transcription. Its ability to bind to DNA and RNA makes it a valuable tool for understanding the molecular mechanisms underlying these processes. Additionally, the recombinant form of KIN17 is used in various biochemical assays and structural studies to elucidate its function and interactions with other proteins and nucleic acids .

Storage and Handling

For optimal stability, the recombinant human KIN protein should be stored at 4°C for short-term use and at -20°C for long-term storage. It is important to avoid repeated freeze-thaw cycles to maintain the protein’s integrity . The protein is typically supplied in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, and 20% glycerol .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.